In lung and breast cancer cells, PARP7 loss-of-function reduces cell proliferation and survival through downregulation of the transcription factor FRA1 (also known as FOSL1), which inhibits the interferon regulatory factors IRF1 and IRF3. The gene discussed is TIPARP; the disease is breast carcinoma.